115 related articles for article (PubMed ID: 19934084)
1. Urinary properdin excretion is associated with intrarenal complement activation and poor renal function.
Siezenga MA; van der Geest RN; Mallat MJ; Rabelink TJ; Daha MR; Berger SP
Nephrol Dial Transplant; 2010 Apr; 25(4):1157-61. PubMed ID: 19934084
[TBL] [Abstract][Full Text] [Related]
2. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients.
Lammerts RGM; Eisenga MF; Alyami M; Daha MR; Seelen MA; Pol RA; van den Born J; Sanders JS; Bakker SJL; Berger SP
Front Immunol; 2019; 10():2511. PubMed ID: 31736953
[TBL] [Abstract][Full Text] [Related]
3. Pitfalls in urinary complement measurements.
van der Pol P; de Vries DK; van Gijlswijk DJ; van Anken GE; Schlagwein N; Daha MR; Aydin Z; de Fijter JW; Schaapherder AF; van Kooten C
Transpl Immunol; 2012 Aug; 27(1):55-8. PubMed ID: 22709941
[TBL] [Abstract][Full Text] [Related]
4. Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage.
Nagamachi S; Ohsawa I; Suzuki H; Sato N; Inoshita H; Hisada A; Honda D; Shimamoto M; Shimizu Y; Horikoshi S; Tomino Y
BMC Nephrol; 2014 May; 15():82. PubMed ID: 24885016
[TBL] [Abstract][Full Text] [Related]
5. Complement activation by tubular cells is mediated by properdin binding.
Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
[TBL] [Abstract][Full Text] [Related]
6. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
Kusunoki Y
Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis.
Honkanen E; Teppo AM; Meri S; Lehto T; Grönhagen-Riska C
Nephrol Dial Transplant; 1994; 9(11):1553-9. PubMed ID: 7870341
[TBL] [Abstract][Full Text] [Related]
8. Urinary protein and enzyme excretion as markers of tubular damage.
D'Amico G; Bazzi C
Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):639-43. PubMed ID: 14564202
[TBL] [Abstract][Full Text] [Related]
9. Complement activation products in the urine from proteinuric patients.
Morita Y; Ikeguchi H; Nakamura J; Hotta N; Yuzawa Y; Matsuo S
J Am Soc Nephrol; 2000 Apr; 11(4):700-707. PubMed ID: 10752529
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
[TBL] [Abstract][Full Text] [Related]
12. [Terminal complement complex (TCC) levels in urine in patients with renal diseases].
Yasuda K
Hokkaido Igaku Zasshi; 2001 Mar; 76(2):71-84. PubMed ID: 11344904
[TBL] [Abstract][Full Text] [Related]
13. Renal disorders involved in the pathophysiology of urinary excretion of a-1 microglobulin in patients with glomerulopathies.
Romão EA; Coimbra TM; Costa RS; Vieira Neto OM; Reis MA; Rodrigues Júnior AL; Ribeiro RA; Ravinal RC; Dantas M
Clin Nephrol; 2009 Dec; 72(6):473-81. PubMed ID: 19954725
[TBL] [Abstract][Full Text] [Related]
14. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
[TBL] [Abstract][Full Text] [Related]
15. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases.
Szeto CC; Lai KB; Chow KM; Szeto CY; Yip TW; Woo KS; Li PK; Lai FM
Clin Chim Acta; 2005 Nov; 361(1-2):182-90. PubMed ID: 15996647
[TBL] [Abstract][Full Text] [Related]
16. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
[TBL] [Abstract][Full Text] [Related]
17. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
[TBL] [Abstract][Full Text] [Related]
18. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.
Triolo G; Giardina E; Casiglia D; Scarantino G; Bompiani GD
Clin Exp Immunol; 1991 Apr; 84(1):53-8. PubMed ID: 2015712
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation.
Fernández-Fresnedo G; Plaza JJ; Sánchez-Plumed J; Sanz-Guajardo A; Palomar-Fontanet R; Arias M
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii47-51. PubMed ID: 15192136
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of urinary factor H excretion in patients with idiopathic membranous nephropathy].
Endo M; Fuke Y; Ohi H; Satomura A; Fukuda N; Fujita T; Matsumoto K
Nihon Jinzo Gakkai Shi; 2007; 49(5):499-504. PubMed ID: 17695812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
